The CSL Ltd (ASX: CSL) share price has fallen to its lowest level in almost a decade.
On Monday, shares in the biotech giant dropped to $140.93, marking the lowest level since December 2017.
At the time of writing, the CSL share price has edged slightly higher to $141.30, though it remains down 3.40% for today.
The decline caps off a difficult period for investors. CSL shares have now fallen more than 20% over the past month and are down roughly 45% over the past year.
This makes it one of the weakest performers among ASX healthcare heavyweights.
Image source: Getty Images
Investor sentiment turns bearish
One major factor behind the weakness appears to be a major shift in investor sentiment.
CSL was once widely viewed as one of the…
